Continuity on the Management Board of Bertrandt AG Ehningen, March 24, 2023 – Continuity on the Management Board of Bertrandt AG. Michael Lücke (Member of the Management Board – Sales) and Markus Ruf (Member of the Management Board – Finance) have been confirmed in their positions and have been appointed for a further five years.… Read More »
Interest in psychedelics as therapeutics has risen in recent years, spurred by studies that have found that the once-maligned drugs used in conjunction with therapy can help in the treatment of psychiatric patients. Amid a rush to commercialize a suite of newly developed products, Massachusetts General Hospital (MGH) has begun a new Center for the… Read More »
Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »
This week, Raley’s, a grocery chain based in California, released its first-ever Raley’s 2020 Impact Report “Imagine a grocery store with a higher purpose,” the landing page for the company’s social impact resources calls us to do. In today’s post, I explore — or chew on, if you will — Raley’s Report through the lens… Read More »
Health Tech Apr 1, 2021• By JESSICA DaMASSA, WTF HEALTH What’s better than being the CEO of one blazing-hot disruptive health tech company that’s raised $ 450M to build “the internet of healthcare”? How about becoming the CEO of a second company – a new managed Medicaid health plan company – that’s to be built… Read More »